Physician profile
Patrick W Ohara
NPI 1508972233
$743.82
in general payments reported to CMS, 2019-2025
18 companies · $91.56 in 2025
The $91.56 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $286 · 2020: $93.11 · 2021: $150 · 2022: $38.99 · 2023: $30.02 · 2024: $54.04 · 2025: $91.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $175.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $248.23 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $119.60 | 2019 | |
| Pfizer INC. | $68.89 | 2019-2025 | |
| Edwards Lifesciences Corporation | $41.65 | 2025 | |
| Allergan, INC. | $39.50 | 2020 | |
| Novo Nordisk INC | $29.98 | 2024 | Wegovy, Rybelsus, Ozempic |
| Merck Sharp & Dohme LLC | $25.81 | 2019-2020 | |
| Astellas Pharma US INC | $19.98 | 2019 | |
| Janssen Pharmaceuticals, INC | $19.21 | 2025 | Spravato |
| Philips North America LLC | $18.94 | 2019 | |
| Circassia INC. | $17.93 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.40 | 2019 | |
| Zyla Life Sciences, INC. | $15.96 | 2020 | |
| Assertio Therapeutics, INC. | $14.47 | 2020 | |
| Sunovion Pharmaceuticals INC. | $12.42 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $11.33 | 2019 | |
| Glaxosmithkline, LLC. | $11.28 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $11.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Ohara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.